These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1005 related articles for article (PubMed ID: 34672420)
21. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. Huang G; Zhang J; Gong L; Huang Y; Liu D BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809 [TBL] [Abstract][Full Text] [Related]
22. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC. Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872 [TBL] [Abstract][Full Text] [Related]
23. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer. Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391 [TBL] [Abstract][Full Text] [Related]
24. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma. Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463 [TBL] [Abstract][Full Text] [Related]
25. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
26. Development of prognostic model incorporating a ferroptosis/cuproptosis-related signature and mutational landscape analysis in muscle-invasive bladder cancer. Hao S; Yang Z; Wang G; Cai G; Qin Y BMC Cancer; 2024 Aug; 24(1):958. PubMed ID: 39107713 [TBL] [Abstract][Full Text] [Related]
27. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer. Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956 [TBL] [Abstract][Full Text] [Related]
28. Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck. Li C; Wang X; Qin R; Zhong Z; Sun C Front Genet; 2021; 12():698040. PubMed ID: 34539737 [TBL] [Abstract][Full Text] [Related]
29. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
30. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J Front Immunol; 2021; 12():665407. PubMed ID: 34177903 [TBL] [Abstract][Full Text] [Related]
31. A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer. Yang L; Li C; Qin Y; Zhang G; Zhao B; Wang Z; Huang Y; Yang Y Front Oncol; 2021; 11():686044. PubMed ID: 34422642 [TBL] [Abstract][Full Text] [Related]
32. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma. Gao X; Wu Y; Yu W; Li H Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574 [TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
34. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma. Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224 [TBL] [Abstract][Full Text] [Related]
35. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma. Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578 [TBL] [Abstract][Full Text] [Related]
36. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma. Xu F; Zhang H; Chen J; Lin L; Chen Y Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430 [TBL] [Abstract][Full Text] [Related]
37. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
38. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Lei T; Qian H; Lei P; Hu Y Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683 [TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma. Shi X; Dong A; Jia X; Zheng G; Wang N; Wang Y; Yang C; Lu J; Yang Y Front Immunol; 2022; 13():992990. PubMed ID: 36311764 [TBL] [Abstract][Full Text] [Related]
40. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma. Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]